-
effectivehealthcare.ahrq.gov/products/infantile-hemangioma/clinician
-
effectivehealthcare.ahrq.gov/products/hemorrhage-postpartum/clinician
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d1.xlsx
January 01, 2024 - Draft - Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: Appendix D1 Tables
Table D-1. Study Characteristic
Author, year Trial name NCT # Key Questions Study design Funding source Follow-up Assessment Timepoints
Indicate all timepoints at which follow-up assessments were completed in months.…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-proof_research.pdf
June 01, 2010 - components, and organizational structure required for a network to
support large-scale, population-based studies
-
effectivehealthcare.ahrq.gov/sites/default/files/substanceabuse_hi_impact.pdf
January 01, 2012 - meeting with FDA for the implant, and that FDA will not require additional
clinical efficacy or safety studies
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
December 01, 2014 - common adverse events reported in
patients taking lesinurad with allopurinol in the CLEAR1 and CLEAR2 studies
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization_research.pdf
January 01, 2011 - Utilization of anticancer biologic products among
Medicare beneficiaries, by diagnostic cancer subchapter,
2006-2009
Anticancer Biologics Data Points #7
Fewer than 50 percent of
beneficiaries with bevacizumab
orders had a cancer diagnosis
in the prior 6 months. This was
driven by the biologic’s off-label
use …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0371_11-23-2010.pdf
January 01, 2010 - Effective Health Care
Topic Number: 0313
Document Completion Date: 12-12-11
1
Results of Topic Selection Process & Next Steps
Outcomes of serious mental illness will go forward for refinement as a systematic review. The scope of
this topic, including populations, interventions, comparators, and…
-
effectivehealthcare.ahrq.gov/products/urinary-incontinence-treatment/research-protocol
-
effectivehealthcare.ahrq.gov/products/eccs-2015/white-paper-2015-1
-
effectivehealthcare.ahrq.gov/products/family-engagement/protocol
-
effectivehealthcare.ahrq.gov/products/diabetes-behavior-programs/clinician
-
effectivehealthcare.ahrq.gov/products/binge-eating/clinician
-
effectivehealthcare.ahrq.gov/products/disruptive-behavior/research
-
effectivehealthcare.ahrq.gov/products/antibiotics-respiratory-infection/clinician
-
effectivehealthcare.ahrq.gov/products/procalcitonin/research
-
effectivehealthcare.ahrq.gov/products/celiac-disease/clinician
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-translation-c-diff-treatment-clinical-pathway.pdf
November 01, 2019 - No studies were identified that directly
impacted clinical care outlined within the clinical pathway … Studies in
health technology and informatics. 2010;160(Pt
2):806-10. PubMed PMID: 20841797. … AMSTAR
2: a critical appraisal tool for systematic reviews
that include randomised or non-randomised
studies
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
October 01, 2015 - Two phase III studies are ongoing in patients who are 6–11 years
old and homozygous for F508del and … for the F508del mutation; the agency is expected to render a decision July 5, 2015.12
Two phase III studies … Two 24-week phase 3 studies of lumacaftor in
combination with ivacaftor met primary endpoint
with
-
effectivehealthcare.ahrq.gov/sites/default/files/analytic-frameworks.ppt
December 09, 2009 - AHRQ Slide Template 2009
Analytic Frameworks
Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Methods Guide for Effectiveness and Comparative Effectiveness
Reviews
Analytic Frameworks
Systematic Review Process Overview
Systematic Review Process Overview
This slide illustrates the steps i…